patisiran

FDA Drug Profile — Onpattro

patisiran is listed in the FDA National Drug Code directory with 1 NDC code, marketed under brand name including Onpattro. Available dosage form: injection, lipid complex.

Drug details

Generic Name
patisiran
Brand Names
Onpattro
Application Number
NDA210922
Sponsor
Alnylam Pharmaceuticals, Inc.
NDC Codes
1
Dosage Forms
INJECTION, LIPID COMPLEX
Routes
INTRAVENOUS
Active Ingredients
PATISIRAN SODIUM

Indications and Usage

1 INDICATIONS AND USAGE ONPATTRO is indicated for the treatment of the polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults. ONPATTRO contains a transthyretin-directed small interfering RNA and is indicated for the treatment of the polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults.

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.